Bleomycin electrosclerotherapy (BEST) for the treatment of vascular malformations. An International Network for Sharing Practices on Electrochemotherapy (InspECT) study group report
, , , , , , , , , , , , , , und
21. Juni 2023
Über diesen Artikel
Artikel-Kategorie: Review
Online veröffentlicht: 21. Juni 2023
Seitenbereich: 141 - 149
Eingereicht: 26. Mai 2023
Akzeptiert: 03. Juni 2023
DOI: https://doi.org/10.2478/raon-2023-0029
Schlüsselwörter
© 2023 Tobian Muir et al., published by Sciendo
This work is licensed under the Creative Commons Attribution 4.0 International License.
FIGURE 1.

FIGURE 2.

Clinical studies and case reports using bleomycin electrosclerotherapy40,41,42,43,44,45
McMorrow |
Venous malformation | 1 | Reduced dose: 1/3 of the standard dose | Not reported | Not reported | Considerable improvement after 6 unsuccessful sessions with bleomycin | Case report with poor respiratory function | |
Horbach |
Hypertrophic capillary malformations | 5 pts. (out of 20 planned) | 0.25 mg or units/cm3 | Plate & needle | Not reported | 7–8 weeks |
Randomized controlled pilot trial | |
Dalmady |
Lymphatic malformation | 1 | 0.5 mg/kg (5.4 mg) | Needle | 1st session: 68 applications |
63% growth-corrected volume decrease. |
Case report | |
Wohlgemuth |
Venous malformations | 17 pts. (20 lesions) | Calculated based on the size of the lesion. |
Needle & finger | Not reported | 3-month post-therapy Changes in volume MRI: Volume reduction,%: | ||
> 90% | 9 lesions | Retrospective observational case study | ||||||
> 70% in < 90% | 6 lesions | |||||||
> 50% in < 70% | 2 lesions | |||||||
< 35% | 2 lesions | |||||||
No response | 1 lesion | |||||||
Kostusiak |
Various vascular malformations | 30 pts. |
Calculated based on the size of the lesion. |
Needle & finger | Not reported | 17 Complete Response |
Prospective observational case study |
|
Krt |
Arteriovenous malformation | 1 | 750 IU BLM intralesional | Plate | 15 | CR 18 months after BEST | Case report |
International Society for the Study of Vascular Anomalies (ISSVA) classification for vascular anomalies 2018
Infantile hemangioma | Kaposiform hemangioendothelioma | Capillary malformation (CM) | CVM, CLM | |
Congenital hemangioma | Retiform hemangioendothelioma | Lymphatic malformation (LM) | LVM. CLVM | |
Tufted hemangioma | PILA. Dabska tumor | Epithelioid hemangioendothelioma | Venous malformation (VM) | CAVM |
Spindle-cell hemangioma | Composite hemangioendothelioma | Angiosarcoma | Arteriovenous malformation (AVM) | |
Epithelioid hemangioma | Kaposi sarcoma | Arteriovenous fistula | CLAVM | |
Pyogenic granuloma |